Matches in SemOpenAlex for { <https://semopenalex.org/work/W4300979576> ?p ?o ?g. }
- W4300979576 abstract "Protease inhibitors are among the most powerful antiviral drugs. Nirmatrelvir is the first protease inhibitor specifically developed against the SARS-CoV-2 protease 3CLpro that has been licensed for clinical use. To identify mutations that confer resistance to this protease inhibitor, we engineered a chimeric vesicular stomatitis virus (VSV) that expressed a polyprotein composed of the VSV glycoprotein (G), the SARS-CoV-2 3CLpro, and the VSV polymerase (L). Viral replication was thus dependent on the autocatalytic processing of this precursor protein by 3CLpro and release of the functional viral proteins G and L, and replication of this chimeric VSV was effectively inhibited by nirmatrelvir. Using this system, we applied nirmatrelvir to select for resistance mutations. Resistance was confirmed by retesting nirmatrelvir against the selected mutations in additional VSV-based systems, in an independently developed cellular system, in a biochemical assay, and in a recombinant SARS-CoV-2 system. We demonstrate that some mutants are cross-resistant to ensitrelvir and GC376, whereas others are less resistant to these compounds. Furthermore, we found that most of these resistance mutations already existed in SARS-CoV-2 sequences that have been deposited in the NCBI and GISAID databases, indicating that these mutations were present in circulating SARS-CoV-2 strains." @default.
- W4300979576 created "2022-10-04" @default.
- W4300979576 creator A5008583952 @default.
- W4300979576 creator A5019310326 @default.
- W4300979576 creator A5024671557 @default.
- W4300979576 creator A5025601555 @default.
- W4300979576 creator A5026555929 @default.
- W4300979576 creator A5043031636 @default.
- W4300979576 creator A5044697154 @default.
- W4300979576 creator A5047271069 @default.
- W4300979576 creator A5057183562 @default.
- W4300979576 creator A5065326739 @default.
- W4300979576 creator A5067224287 @default.
- W4300979576 creator A5068638612 @default.
- W4300979576 creator A5075857776 @default.
- W4300979576 creator A5080246153 @default.
- W4300979576 creator A5080368267 @default.
- W4300979576 date "2023-01-11" @default.
- W4300979576 modified "2023-10-18" @default.
- W4300979576 title "SARS-CoV-2 3CL <sup>pro</sup> mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376" @default.
- W4300979576 cites W1969323021 @default.
- W4300979576 cites W1970294718 @default.
- W4300979576 cites W1971439989 @default.
- W4300979576 cites W1989069389 @default.
- W4300979576 cites W1998139623 @default.
- W4300979576 cites W2010082441 @default.
- W4300979576 cites W2025880126 @default.
- W4300979576 cites W2047858844 @default.
- W4300979576 cites W2050066735 @default.
- W4300979576 cites W2078145018 @default.
- W4300979576 cites W2089695993 @default.
- W4300979576 cites W2098213772 @default.
- W4300979576 cites W2100593398 @default.
- W4300979576 cites W2108018232 @default.
- W4300979576 cites W2115167726 @default.
- W4300979576 cites W2128955394 @default.
- W4300979576 cites W2132629607 @default.
- W4300979576 cites W2146397496 @default.
- W4300979576 cites W2170123187 @default.
- W4300979576 cites W2525631210 @default.
- W4300979576 cites W2544460047 @default.
- W4300979576 cites W2559258718 @default.
- W4300979576 cites W2587970647 @default.
- W4300979576 cites W2605343262 @default.
- W4300979576 cites W2753581206 @default.
- W4300979576 cites W2785769442 @default.
- W4300979576 cites W3004280078 @default.
- W4300979576 cites W3011701533 @default.
- W4300979576 cites W3040116040 @default.
- W4300979576 cites W3042369822 @default.
- W4300979576 cites W3088885706 @default.
- W4300979576 cites W3089439163 @default.
- W4300979576 cites W3094021184 @default.
- W4300979576 cites W3121995178 @default.
- W4300979576 cites W3126562684 @default.
- W4300979576 cites W3128930814 @default.
- W4300979576 cites W3158358829 @default.
- W4300979576 cites W3185215839 @default.
- W4300979576 cites W3186179742 @default.
- W4300979576 cites W3189646261 @default.
- W4300979576 cites W3195131507 @default.
- W4300979576 cites W3199620752 @default.
- W4300979576 cites W3200315064 @default.
- W4300979576 cites W3206993253 @default.
- W4300979576 cites W4200137031 @default.
- W4300979576 cites W4212949239 @default.
- W4300979576 cites W4220921077 @default.
- W4300979576 cites W4221056874 @default.
- W4300979576 cites W4224253542 @default.
- W4300979576 cites W4224285099 @default.
- W4300979576 cites W4224863638 @default.
- W4300979576 cites W4224952045 @default.
- W4300979576 cites W4250950851 @default.
- W4300979576 cites W4281672110 @default.
- W4300979576 cites W4283730960 @default.
- W4300979576 cites W4290694860 @default.
- W4300979576 cites W4293866320 @default.
- W4300979576 cites W4295014386 @default.
- W4300979576 cites W4295358187 @default.
- W4300979576 cites W4308683905 @default.
- W4300979576 cites W4315436946 @default.
- W4300979576 doi "https://doi.org/10.1126/scitranslmed.abq7360" @default.
- W4300979576 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36194133" @default.
- W4300979576 hasPublicationYear "2023" @default.
- W4300979576 type Work @default.
- W4300979576 citedByCount "50" @default.
- W4300979576 countsByYear W43009795762022 @default.
- W4300979576 countsByYear W43009795762023 @default.
- W4300979576 crossrefType "journal-article" @default.
- W4300979576 hasAuthorship W4300979576A5008583952 @default.
- W4300979576 hasAuthorship W4300979576A5019310326 @default.
- W4300979576 hasAuthorship W4300979576A5024671557 @default.
- W4300979576 hasAuthorship W4300979576A5025601555 @default.
- W4300979576 hasAuthorship W4300979576A5026555929 @default.
- W4300979576 hasAuthorship W4300979576A5043031636 @default.
- W4300979576 hasAuthorship W4300979576A5044697154 @default.
- W4300979576 hasAuthorship W4300979576A5047271069 @default.
- W4300979576 hasAuthorship W4300979576A5057183562 @default.
- W4300979576 hasAuthorship W4300979576A5065326739 @default.
- W4300979576 hasAuthorship W4300979576A5067224287 @default.